Articles

Videos

Podcasts

Clinical

As we learn more about inflammatory syndromes, we may get better at using laboratory tests to identify and isolate the actual cellular and chemical processes that drive them.

Addressing the Mystery of Long Hauler COVID: The Time is Now

Companies, FDA caught unaware by surge in virus cases, leading to shortage of critical items.

COVID-19 Affects Development of Medical Devices

The study included the BNT162b2 and CoronaVac vaccines, which are the only COVID-19 vaccines authorized for emergency use in Hong Kong.

Study: COVID-19 Vaccination Not Associated With Increased Risk of Heart Attack, Stroke

More than three-quarters of deaths averted were attributed to the direct protection against severe symptoms provided by vaccination, leading to lower mortality rates.

Modeling Study Finds COVID-19 Vaccines Prevented 20 Million Deaths Globally In First Year of Availability

Infection in pregnancy increases the risk for preterm delivery and other adverse pregnancy outcomes, including stillbirth.

Research Continues Around COVID-19 Vaccinations and Pregnancy

At 1 month, a 50-µg booster dose of mRNA-1273.214 had a potent neutralizing antibody response against the Omicron variants in all individuals, regardless of prior infection.

New Clinical Data for Bivalent COVID-19 Booster Candidate Shows Potent Response Against Omicron Variant

The Sanofi-GSK vaccine demonstrated a favorable safety and tolerability profile throughout stage 1 and stage 2 of the VAT08 trial, according to the researchers.

Vaccine Candidate Shows Efficacy Against Omicron with COVID-19 Beta-Containing Vaccine

Pharmacy and public health have a long history of collaboration during an emergency.

Examining the Partnership Between Pharmacy and Public Health During the COVID-19 Pandemic

Kai Zhao, PhD, director of the Nasal Physiology and Therapeutic Center in the Department of Otolaryngology at Ohio State University College of Medicine, discusses his research investigating the persistence of taste and smell loss among patients who have been infected and reinfected with COVID-19.

Expert: COVID-19 Vaccination Does Not Completely Protect Against the Virus’s Impact on Taste, Smell Function

Analysis shows that individuals who received treatment within 3 days of symptom onset with tixagevimab and cilgavimab reduced their risk by 88% compared with the placebo.

Study: Evusheld Offers Significant Prevention Against Severe COVID-19 Disease, Death

® Coronavirus Disease Resource Center is a comprehensive resource for clinical news and expert insights on COVID-19, an infectious disease caused by the SARS-CoV-2 virus, including vaccine information and treatments for the disease.